Advaxis therapy improves survival rates in cervical cancer patients

(Reuters) - Advaxis Inc said its experimental cancer vaccine was found more effective in improving survival rates of cervical cancer patients than standard therapy, validating the technology behind its pipeline of cancer treatments.